VX-522 mRNA therapy clinical trials

A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)

This study is testing a new medicine, VX-522, for adults with cystic fibrosis (CF) whose current treatments aren't effective. It aims to see if the medicine is safe, well-tolerated, and helpful for improving their condition. This is an important step in finding new ways to manage CF.